ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
CDC’s Clinical Standardization Programs
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 266966" data-attributes="member: 13851"><p><strong><em>High-quality disease biomarker tests are critical for the correct diagnosis and treatment of patients, accurate interpretation of research data, and effective use of research findings in health care. CDC’s Clinical Standardization Program (CDC CSP) assists researchers and laboratories with assessing and improving the analytical performance of biomarker tests performed in patient care, public health, and research. <u>CDC CSP develops and applies reference methods, materials, and protocols to consistently calibrate biomarker tests across instruments and laboratories and to assess and improve other analytical performance characteristics, such as analytical specificity</u>. <u>CDC CSP works with test manufacturers and laboratories operating in-house developed tests to correctly calibrate tests</u>.</em></strong><em> <strong><u>Additional programs help clinical and research laboratories monitor the accuracy and reliability of tests over time</u>. <u>Furthermore, CDC CSP collaborates with researchers on the development of reference intervals and on using new and emerging biomarkers in patient care and public health</u>. <u>CDC CSP provides comprehensive programs for traditional blood lipids, testosterone, estradiol, vitamin D, and free thyroxine</u>. <u>Programs for free testosterone, parathyroid hormones, apolipoproteins, and angiotensin peptides will be available soon</u>. <u>CDC CSP collaborated with members of the Partnership for the Accurate Testing of Hormones(PATH) and established reference intervals for testosterone in men</u>. <u>CDC CSP is currently working to develop reference intervals for testosterone in women and for estradiol in postmenopausal women</u>. <u>A CDC CSP interlaboratory study on free thyroxine measurements showed high variability in calibration accuracy among free thyroxine assays</u>. <u>CDC CSP is using its reference methods and materials to minimize this variability</u>. <u>It is anticipated that assay recalibration may change measurement values for some tests by up to 50%</u>. CDC CSP is working with PATH and the International Federation for Clinical Chemistry and Laboratory </strong></em><strong><em>Medicin</em></strong><em><strong>e (IFCC) to educate stakeholders about the upcoming change in free thyroxine m</strong></em><strong><em>easurements.</em></strong></p></blockquote><p></p>
[QUOTE="madman, post: 266966, member: 13851"] [B][I]High-quality disease biomarker tests are critical for the correct diagnosis and treatment of patients, accurate interpretation of research data, and effective use of research findings in health care. CDC’s Clinical Standardization Program (CDC CSP) assists researchers and laboratories with assessing and improving the analytical performance of biomarker tests performed in patient care, public health, and research. [U]CDC CSP develops and applies reference methods, materials, and protocols to consistently calibrate biomarker tests across instruments and laboratories and to assess and improve other analytical performance characteristics, such as analytical specificity[/U]. [U]CDC CSP works with test manufacturers and laboratories operating in-house developed tests to correctly calibrate tests[/U].[/I][/B][I] [B][U]Additional programs help clinical and research laboratories monitor the accuracy and reliability of tests over time[/U]. [U]Furthermore, CDC CSP collaborates with researchers on the development of reference intervals and on using new and emerging biomarkers in patient care and public health[/U]. [U]CDC CSP provides comprehensive programs for traditional blood lipids, testosterone, estradiol, vitamin D, and free thyroxine[/U]. [U]Programs for free testosterone, parathyroid hormones, apolipoproteins, and angiotensin peptides will be available soon[/U]. [U]CDC CSP collaborated with members of the Partnership for the Accurate Testing of Hormones(PATH) and established reference intervals for testosterone in men[/U]. [U]CDC CSP is currently working to develop reference intervals for testosterone in women and for estradiol in postmenopausal women[/U]. [U]A CDC CSP interlaboratory study on free thyroxine measurements showed high variability in calibration accuracy among free thyroxine assays[/U]. [U]CDC CSP is using its reference methods and materials to minimize this variability[/U]. [U]It is anticipated that assay recalibration may change measurement values for some tests by up to 50%[/U]. CDC CSP is working with PATH and the International Federation for Clinical Chemistry and Laboratory [/B][/I][B][I]Medicin[/I][/B][I][B]e (IFCC) to educate stakeholders about the upcoming change in free thyroxine m[/B][/I][B][I]easurements.[/I][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
CDC’s Clinical Standardization Programs
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top